AlphAIAlphAI — Financial news for AI agents
stocktitan.netSEP 181 min read$APLM

Apollomics (NASDAQ: APLM) COO now holds 20,100 shares

Apollomics (APLM) reported that COO Chen Yi-Kuei's 5,000 restricted stock units vested into 5,000 Class A shares on September 15, 2026, increasing his direct holdings to 20,100 shares. He was also granted an option for 8,000 shares at $23.18 each, vesting in 2027. He indirectly holds 121,248 shares through Maxpro Investment Co.

Original reporting
stocktitan.net
Published Sep 18, 2026, 12:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 3:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$APLM
Neutral
high confidence
Mentioned
$APLM
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$APLMNeutralLow
01

Why it matters

The vesting and option grant modestly increase insider ownership without immediate market impact.

02

Market read

Minor insider activity; unlikely to move the stock price materially.

03

What to watch

Potential future dilution from option exercises in 2027.

Relevance 4/10Novelty 4/10Timing: post‑vest reporting

Background

Form 4 filing discloses insider equity awards for Apollomics COO.

Company-level read

Ticker impact

$APLMNeutralHigh confidence
Context

COO Chen Yi-Kuei vested 5,000 RSUs and received an 8,000‑share stock option grant, increasing his direct holdings to 20,100 shares.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

The transaction size is modest for a micro‑cap and involves no cash sale, so market reaction is expected to be negligible.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Even small insider grants can signal confidence; watch for future insider buying.

Key entities

  • Company
    Apollomics Inc.

    Biotech firm listed on NASDAQ under ticker APLM.

  • Executive
    Chen Yi-Kuei

    Chief Operating Officer of Apollomics.

Read at source← All news

Related articles

AUG 12
$APLMMedAI 8/10

Apollomics Announces $10 Million Private Placement; Stock Down

Apollomics Inc. (APLM) said it entered definitive subscription agreements for a roughly $10 million private placement. It includes cash subscriptions for 533,334 Class A shares at $15.00 (about $8.0 million) and conversion of a $2 million unsecured convertible note into 166,667 shares at $12.00. Closing is expected around Aug. 14, 2026. APLM shares were $18.16 Tuesday.

rttnews.com4 min
OCT 8
$BAHigh

Is Boeing (BA) Fully Valued After Its $14.7b PAC 3 Seeker Contract?

Boeing (BA) secured a $14.7b contract from Lockheed Martin for PAC-3 Missile Segment Enhancement seeker production. Shares closed at $188.32, down 15.59% over 90 days and 17.32% year-to-date. Analysts debate valuation, with some seeing it as 17.7% overvalued at $188.32 vs. a fair value of $160.01, while a DCF model suggests a fair value of $376.49.

finance.yahoo.com2 min
OCT 8
$MUMed

Veteran analyst aggressively resets Micron stock target on 3-5 year run

D.A. Davidson analyst Gil Luria raised Micron's (MU) price target to $3,000, citing a 3-5 year growth trajectory driven by AI demand. He argues memory is now a 'mission-critical' component, with long-term supply agreements reducing cyclicality. Micron's Q4 sales surged to $54.23B, with strong guidance and increased long-term commitments. Bank of America also raised its revenue estimates, but differs on valuation. MU trades at 5.94x forward earnings, below sector median.

finance.yahoo.com2 min